Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
Kristina Wallengren , Fabio Scano, Paul Nunn, Bruce Margot, Sandile S.S. Buthelezi, Brian Williams, Alexander Pym, Elisabeth Y. Samuel, Fuad Mirzayev, Wilfred Nkhoma, Lindiwe Mvusi, and Yogan Pillay
Author affiliations: KwaZulu-Natal Research Institute for Tuberculosis and HIV, University of KwaZulu-Natal, Durban, South Africa (K. Wallengren); World Health Organization, Geneva, Switzerland (F. Scano, P. Nunn, F. Mirzayev); Department of Health, Pietermaritzburg, South Africa (B. Margot, S.S.S. Buthelezi); South African Centre for Epidemiological Modelling and Analysis, Stellenbosch, South Africa (B. Williams); Medical Research Council, Durban (A. Pym); Inkosi Albert Luthuli Central Hospital, Durban (E.Y. Samuel); World Health Organization, Harare, Zimbabwe (W. Nkhoma); Department of Health, Pretoria, South Africa (L. Mvusi, Y. Pillay)
Figure 1. Prevalence of drug-resistant tuberculosis (TB) in the 11 districts of KwaZulu-Natal, South Africa, 2001–2007. A) Multidrug-resistant (MDR) TB; B) extensively drug-resistant (XDR) TB. White bar sections, Church of Scotland Hospital; black bar sections, the rest of KwaZulu-Natal Province.
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.